Princeton Global Asset Management LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Princeton Global Asset Management LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$10,000
-9.1%
1,0000.0%0.00%
-25.0%
Q1 2021$11,000
-26.7%
1,0000.0%0.00%
-20.0%
Q4 2020$15,000
+7.1%
1,0000.0%0.01%
-16.7%
Q3 2020$14,000
+75.0%
1,0000.0%0.01%
+200.0%
Q2 2020$8,000
+100.0%
1,0000.0%0.00%0.0%
Q1 2020$4,0001,0000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders